Speaker Profile
MD, PhD, Assistant Professor, Director Solid Tumor Cell Therapy, Stanford
Biography
Dr. Betof Warner is a board certified medical oncologist specializing in advanced melanoma treatment. She serves as the Director of Melanoma Medical Oncology, Director of Solid Tumor Cellular Therapy, and coDirector of the Pigmented Lesion and Melanoma Program. A pioneer in tumor infiltrating lymphocyte (TIL) therapy, she leads the Melanoma Cutaneous Oncology Clinical Research Group, focusing on tumor response to immunotherapy. Recognized for her expertise in central nervous system metastases and novel cellular therapies, she's collaborated globally and received accolades from ASCO, NIH, and the Melanoma Research Foundation. Dr. Betof Warner is an active member of several professional organizations, including the American Association for Cancer Research and the Society for Immunotherapy of Cancer.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2024 Award Ceremony
Pioneer Honoree: Stanley Riddell, Fred Hutchinson
Pioneer Honoree: George Coukos, Ludwig Cancer Center
- Keynote: Engineering Synthetic T Cell States for Cancer Rejection
- George Coukos, Ludwig Cancer Center
- Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
- Stanley Riddell, Fred Hutchinson
- Allison Betof Warner, Stanford
- Lawrence Fong, UCSF - Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
Chair: Jean Xu, Janssen Pharmaceuticals
- Amanda Pace, Sonoma Bio
- Laura Deschenes, Sana Biotechnology - Evolving Case Law and Practical Strategies for Immunotherapy Patents
- Janet Xiao, Morrison & Foerster LLP
- Emerging Clinical Data in Oncology Cell Therapeutics
Chair: Andrew Allen, Gritstone bio, Inc.
- Robert Meehan, Moderna - Scientific Advancements in Individualized Cell Therapies in Oncology ( PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- Robert Meehan, Moderna
- Dirk Nagorsen, Affini-T Therapeutics - AI-Enhanced Approaches in Cell Therapy Development
Chair: Suchit Jhunjhunwala, Genentech
- Brian Weitzner, Outpace Bio
- PMWC Showcase
- Arun Wiita, UCSF
